Zentalis Pharmaceuticals (ZNTL) Treasury Shares (2019 - 2020)

Zentalis Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 158.33% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $5.4 million (up 158.33% YoY), while the FY2025 annual figure was $5.4 million, up 158.33% from the prior year.
• Treasury Shares for Q4 2025 stood at $5.4 million, up from $2.1 million in the prior quarter.
• The five-year high for Treasury Shares was $5.4 million in Q4 2025, with the low at $274195.0 in Q4 2021.
• The 5-year median for Treasury Shares is $1.2 million (2023), against an average of $2.0 million.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares soared 236.59% in 2022, then jumped 32.06% in 2023.
• Zentalis Pharmaceuticals' Treasury Shares stood at $274195.0 in 2021, then jumped by 236.59% to $922901.0 in 2022, then surged by 32.06% to $1.2 million in 2023, then soared by 70.17% to $2.1 million in 2024, then jumped by 158.33% to $5.4 million in 2025.
• Business Quant data shows ZNTL's Treasury Shares at $5.4 million in Q4 2025, $2.1 million in Q4 2024, and $1.2 million in Q4 2023.